Burkhart Erin (CIK 1927648) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-05-20). Recent activity: Sell BMRN (996 shares), Sell BMRN (1,786 shares), Sell BMRN (1,295 shares), Sell BMRN (823 shares), Buy BMRN (5,970 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | Sell | 996 | $59,033 |
| 2025-05-20 | BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | Sell | 1,786 | $105,928 |
| 2025-03-20 | BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | Sell | 1,295 | $92,618 |
| 2025-03-18 | BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | Sell | 823 | $57,149 |
| 2025-03-18 | BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | Buy | 5,970 | $0 |
| 2025-02-25 | BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | Sell | 1,344 | $91,903 |
Source: SEC Form 4 filings · as of 2025-05-20